Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Total Liabilities (2016 - 2025)

Nephros has reported Total Liabilities over the past 16 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Total Liabilities at $3.4 million for Q4 2025, up 31.01% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (up 31.01% YoY), and the annual figure for FY2025 was $3.4 million, up 31.01%.
  • Total Liabilities for Q4 2025 was $3.4 million at Nephros, up from $3.2 million in the prior quarter.
  • Over the last five years, Total Liabilities for NEPH hit a ceiling of $3.5 million in Q4 2023 and a floor of $1.7 million in Q2 2023.
  • Median Total Liabilities over the past 5 years was $2.5 million (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Total Liabilities: crashed 48.5% in 2021 and later soared 83.36% in 2024.
  • Nephros' Total Liabilities stood at $2.9 million in 2021, then decreased by 26.99% to $2.1 million in 2022, then surged by 65.39% to $3.5 million in 2023, then dropped by 25.06% to $2.6 million in 2024, then surged by 31.01% to $3.4 million in 2025.
  • The last three reported values for Total Liabilities were $3.4 million (Q4 2025), $3.2 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.